Inclusion Criteria : 
  -  Age : older than 18 years
  -  WHO ( ECOG ) performance status 0 - 2 
  -  Histological proven HNSCC
  -  HPV negative tumors or HPV positive tumors
  -  Stage III , IVA or IVB HNSCC according to UICC and AJCC guidelines
  -  Tumor classified as irresectable or patient inoperable or patient refused surgery
  -  Tumor extension and localization suitable for radiochemotherapy with curative intent
  -  Simultaneous standard chemotherapy with cisplatin applicable ( no contra - indications ) 
  -  Dental examination and - treatment before start of therapy
  -  For women with childbearing potential and men in reproductive ages adequate contraception . 
  -  Ability of subject to understand character and individual consequences of the clinical trial
  -  Written informed consent ( must be available before enrolment in the trial ) 
Exclusion Criteria : 
  -  Refusal of the patients to take part in the trial
  -  Presence of distant metastases ( UICC stage IVC ) 
  -  Previous radiotherapy in the head and neck region
  -  Second malignancy that is likely to require treatment during the trial intervention or follow - up period or that , in the opinion of the physician , has a considerable risk of recurrence or metastases within the follow - up period
  -  Serious disease or medical condition with life expectancy of less than one year
  -  Participation in competing interventional trial on cancer treatment
  -  Patients who are not suitable for radiochemotherapy
  -  Pregnant or lactating women
  -  Patients not able to understand the character and individual consequences of the trial
  -  Nasopharyngeal Carcinomas